Zimmer Biomet Reports 4.8% Net Sales Increase in Second Quarter

Medical device manufacturer Zimmer Biomet reported second-quarter net sales of $2.177 billion, an increase of 4.8% on a reported basis. Sales also rose 4.7% on a constant currency basis and 4.0% on an organic constant currency basis.

Diluted earnings per share for the quarter were $1.03, marking a 33.8% increase. Adjusted diluted earnings per share reached $2.07.

Zimmer Biomet focuses on developing and manufacturing medical technologies for musculoskeletal treatments, including hip and knee implants and spine products.

The company projects full-year 2026 net sales to grow between 4.0% and 5.0% on a constant currency basis. Adjusted diluted earnings per share for the full year are anticipated to be in the range of $8.75 to $9.05.